Efficacy and Safety of Ulotaront in the Treatment of Schizophrenia: Results of Two 6-Week, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trials

被引：0

作者：

Kane, John ^{[1
]}

Dworak, Heather ^{[1
]}

Koblan, Kenneth ^{[1
]}

Szegedi, Armin ^{[1
]}

Goldman, Robert ^{[1
]}

Li, Yan ^{[1
]}

Fitzgerald, Alison ^{[1
]}

Loebel, Antony ^{[1
]}

Marder, Stephen ^{[1
]}

机构：

[1] Sunovion Pharmaceut Inc, Teaneck, NJ USA

来源：

NEUROPSYCHOPHARMACOLOGY | 2023年 / 48卷

关键词：

Schizophrenia (SCZ); TAAR1; Phase III Trial; Clinical Trial; Ulotaront;

D O I：

暂无

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

P495

引用

页码：351 / 351

页数：1

共 50 条

[21] Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania
Amrollahi, Zohreh
Rezaei, Farzin
Salehi, Bahman
Modabbernia, Amir-Hossein
Maroufi, Azad
Esfandiari, Gholam-Reza
Naderi, Mehrangiz
Ghebleh, Fariba
Ahmadi-Abhari, Seyed-Ali
Sadeghi, Majid
Tabrizi, Mina
Akhondzadeh, Shahin
JOURNAL OF AFFECTIVE DISORDERS, 2011, 129 (1-3) : 327 - 331
[22] Efficacy and safety of itopride in functional dyspepsia: Results of two phase III multicentre, randomized, double-blind, placebo-controlled trials
Talley, Nicholas J.
Tack, Jan
Ptak, Theadore
Gupta, Rajendra
Giguere, Monique
GASTROENTEROLOGY, 2007, 132 (04) : A93 - A93
[23] Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: A 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine
Montgomery, Stuart A.
Tobias, Kathy
Zornberg, Gwen L.
Kasper, Siegfried
Pande, Atul C.
JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (05) : 771 - 782
[24] Randomized, double-blind, placebo, and risperidone-controlled study of lurasidone in the treatment of schizophrenia: Results of an inconclusive 6-week trial
Higuchi, Teruhiko
Iyo, Masaomi
Kwon, Jun Soo
Chou, Yuan-Hwa
Chen, Hsing-Kang
Chen, Jen-Yeu
Chen, Tzu-Ting
Huang, San-Yuan
Lee, Jung-Sik
Saeki, Yuichi
Tanaka, Hisashi
Wang, Tzong-Shi
Wu, Bo-Jian
Katoh, Takao
Ishigouoka, Jun
ASIA-PACIFIC PSYCHIATRY, 2019, 11 (03)
[25] The efficacy and safety of lurasidone in adolescent patients with schizophrenia: Results of functional and quality of life measures from a 6-week, double-blind, placebo-controlled study
Findling, R.
Goldman, R.
Cucchiaro, J.
Deng, L.
Loebel, A.
EUROPEAN PSYCHIATRY, 2017, 41 : S94 - S94
[26] Lurasidone monotherapy in the treatment of bipolar I depression: Safety and tolerability Results of a randomized, double-blind, placebo-controlled, 6-week elevate study
Kato, T.
Ishigooka, J.
Masuda, T.
Watabe, K.
Fujimori, T.
Higuchi, T.
BIPOLAR DISORDERS, 2019, 21 : 131 - 131
[27] Efficacy and Safety of an Asenapine Transdermal Patch (Asenapine Transdermal System, HP-3070) in the Treatment of Adults With Schizophrenia: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 6-Week Inpatient Study
Citrome, Leslie
Walling, David
Zeni, Courtney
Komaroff, Marina
Park, Alexandra
BIOLOGICAL PSYCHIATRY, 2019, 85 (10) : S126 - S126
[28] Efficacy and Safety of an Asenapine Transdermal Patch (Asenapine Transdermal System, HP-3070) in the Treatment of Adults With Schizophrenia: A Phase 3 Randomized, Double-Blind, Placebo-Controlled, 6-Week, Inpatient Study
Citrome, Leslie
Walling, David
Zeni, Courtney
Komaroff, Marina
Park, Alexandra
NEUROPSYCHOPHARMACOLOGY, 2018, 43 : S343 - S344
[29] Favipiravir Treatment of Uncomplicated Influenza in Adults: Results of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials
Hayden, Frederick G.
Lenk, Robert P.
Stonis, Lucille
Oldham-Creamer, Catherine
Kang, Lih Lisa
Epstein, Carol
JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (10): : 1790 - 1799
[30] The efficacy of lurasidone on PANSS subscales in adolescent patients with schizophrenia: Results from a 6-week, double-blind, placebo-controlled, multicenter study
Correll, C.
Goldman, R.
Cucchiaro, J.
Deng, L.
Loebel, A.
EUROPEAN PSYCHIATRY, 2017, 41 : S90 - S91

← 1 2 3 4 5 →